Cargando…

Sources of Antifungal Drugs

Due to their eukaryotic heritage, the differences between a fungal pathogen’s molecular makeup and its human host are small. Therefore, the discovery and subsequent development of novel antifungal drugs are extremely challenging. Nevertheless, since the 1940s, researchers have successfully uncovered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanreppelen, Giel, Wuyts, Jurgen, Van Dijck, Patrick, Vandecruys, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965926/ https://www.ncbi.nlm.nih.gov/pubmed/36836286 http://dx.doi.org/10.3390/jof9020171

Ejemplares similares

S3.4c A pipeline toward the identification of novel antifungal compounds derived from the microbial dark matter
por: Vanreppelen, Giel, et al.
Publicado: (2022)

Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target
por: Demuyser, Liesbeth, et al.
Publicado: (2020)

Fungal persister cells: The basis for recalcitrant infections?
por: Wuyts, Jurgen, et al.
Publicado: (2018)

The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis
por: Baldewijns, Silke, et al.
Publicado: (2021)

Antifungal Activity and Synergism with Azoles of Polish Propolis
por: Gucwa, Katarzyna, et al.
Publicado: (2018)

Striking essential oil: tapping into a largely unexplored source for drug discovery
por: Feyaerts, Adam F., et al.
Publicado: (2020)

In Vitro Assessment of Azole and Amphotericin B Susceptibilities of Malassezia spp. Isolated from Healthy and Lesioned Skin
por: Chebil, Wissal, et al.
Publicado: (2022)

The involvement of the Candida glabrata trehalase enzymes in stress resistance and gut colonization
por: Van Ende, Mieke, et al.
Publicado: (2020)

Antifungal Drugs
por: Houšť, Jiří, et al.
Publicado: (2020)

Cyanobacteria: A Promising Source of Antifungal Metabolites
por: do Amaral, Samuel Cavalcante, et al.
Publicado: (2023)

Current Insights on Antifungal Therapy: Novel Nanotechnology Approaches for Drug Delivery Systems and New Drugs from Natural Sources
por: Sousa, Filipa, et al.
Publicado: (2020)

Antifungal metabolites, their novel sources, and targets to combat drug resistance
por: Choudhary, Megha, et al.
Publicado: (2022)

Endophytic Fungi: A Source of Potential Antifungal Compounds
por: Deshmukh, Sunil K., et al.
Publicado: (2018)

Amphotericin B and Other Polyenes—Discovery, Clinical Use, Mode of Action and Drug Resistance
por: Carolus, Hans, et al.
Publicado: (2020)

Amphidinium spp. as a Source of Antimicrobial, Antifungal, and Anticancer Compounds
por: Orefice, Ida, et al.
Publicado: (2023)

Sulfur Metabolism as a Promising Source of New Antifungal Targets
por: Amich, Jorge
Publicado: (2022)

Use of antifungal drugs in hematology
por: Nucci, Marcio
Publicado: (2012)

Susceptibility Testing of Fungi to Antifungal Drugs
por: Sanguinetti, Maurizio, et al.
Publicado: (2018)

Epigenetic Regulation of Antifungal Drug Resistance
por: Patra, Sandip, et al.
Publicado: (2022)

Repurposing antifungal drugs for cancer therapy
por: Weng, Ningna, et al.
Publicado: (2022)

The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase
por: Siala, Wafi, et al.
Publicado: (2016)

Plant as an Alternative Source of Antifungals against Aspergillus Infections: A Review
por: Tan, Lee Fang, et al.
Publicado: (2022)

Essential oils and their components are a class of antifungals with potent vapour-phase-mediated anti-Candida activity
por: Feyaerts, Adam F., et al.
Publicado: (2018)

Investigating the Antifungal Mechanism of Action of Polygodial by Phenotypic Screening in Saccharomyces cerevisiae
por: Kipanga, Purity N., et al.
Publicado: (2021)

Antifungal Drug Resistance: An Emergent Health Threat
por: Vitiello, Antonio, et al.
Publicado: (2023)

The Microevolution of Antifungal Drug Resistance in Pathogenic Fungi
por: Boyce, Kylie J.
Publicado: (2023)

Sugar Phosphorylation Controls Carbon Source Utilization and Virulence of Candida albicans
por: Wijnants, Stefanie, et al.
Publicado: (2020)

An insight into new strategies to combat antifungal drug resistance
por: Zheng, Yan-Hua, et al.
Publicado: (2018)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
por: McEvoy, Kyle, et al.
Publicado: (2020)

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
por: Kane, Aidan, et al.
Publicado: (2022)

Host Defense Peptides as Templates for Antifungal Drug Development
por: Basso, Virginia, et al.
Publicado: (2020)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

New microbial source of the antifungal allylamine “Terbinafine”
por: Abdel-Kader, Maged S., et al.
Publicado: (2017)

Cyclic Peptides with Antifungal Properties Derived from Bacteria, Fungi, Plants, and Synthetic Sources
por: Helmy, Naiera M., et al.
Publicado: (2023)

Pandemic Response Box(®) library as a source of antifungal drugs against Scedosporium and Lomentospora species
por: Rollin-Pinheiro, Rodrigo, et al.
Publicado: (2023)

The Proteome of the Red Blood Cell: An Auspicious Source of New Insights into Membrane-Centered Regulation of Homeostasis
por: Bosman, Giel J. C. G. M.
Publicado: (2016)

Solid lipid nanoparticles, an effective carrier for classical antifungal drugs
por: Almawash, Saud
Publicado: (2023)

Emerging Polymer-Based Nanosystem Strategies in the Delivery of Antifungal Drugs
por: Xin, Yuan, et al.
Publicado: (2023)

Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
por: Bellmann, Romuald, et al.
Publicado: (2017)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs
por: Quindós, Guillermo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9m2p1o00ejcj6a536ingu4rroo